Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.057,96
-0,63%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adaptimmune Therapeutics PLC (ADAP) Adaptimmune Therapeutics PLC (ADAP) Notizie

Adaptimmune Therapeutics PLC

ADAP
0,5788
-0,0092 (-1,56%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202413:40EDGAR2Form 8-K - Current report
13/11/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:10EDGAR2Form 8-K - Current report
13/11/202415:10EDGAR2Form 8-K - Current report
01/11/202422:00EDGAR2Form 8-K - Current report
23/9/202422:15EDGAR2Form 8-K - Current report
12/8/202413:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202413:05EDGAR2Form 8-K - Current report
12/8/202411:47IHMARKETNEWSU.S. Futures Steady as Markets Await Key Inflation Data, Oil..
02/8/202413:00EDGAR2Form 8-K - Current report
02/8/202402:20BWAdaptimmune Receives U.S. FDA Accelerated Approval of..
16/7/202422:30EDGAR2Form 8-K - Current report
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:15EDGAR2Form 8-K - Current report
15/5/202413:39EDGAR2Form 8-K - Current report
15/5/202413:14EDGAR2Form 8-K - Current report
14/5/202413:34EDGAR2Form 8-K - Current report
06/3/202413:05EDGAR2Form 8-K - Current report
27/2/202414:13EDGAR2Form 8-K - Current report
16/2/202422:05EDGAR2Form 8-K - Current report
31/1/202423:07EDGAR2Form 8-K - Current report
17/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:46EDGAR2Form 8-K - Current report
Apertura: 0,581 Min: 0,5751 Max: 0,6056
Chiusura: 0,588

La tua Cronologia

NASDAQ
ADAP
Adaptimmune Therapeutics
BIT
P1UCY5
NLBNPIT1UCY5 20991231 24...
BOV
BPFR39
Global X Funds
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network